- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
R
RGLS
Regulus Therapeu
3.27
-0.22-6.30%Opening12:54 04/29 EDT
OPEN/PREV CLOSE3.500/3.490
TODAY RANGE3.236-3.597
VOL1.16M
MARKET CAP216.62M
52 WEEK RANGE0.8301-3.730
AVG VOL (3M)1.27M
% TURNOVER1.76%
TURNOVER--
P/E (TTM)-3.9747
% RANGE10.34%
EPS(TTM)-0.8227
P/E(FORWARD)-3.1594
P/B2.803
BVPS1.167
DIVIDEND--
P/S4.911
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP211.89M
SHARES OUTSTANDING66.24M
NEXT EARNINGS05/07-05/12
FREE FLOAT64.80M
LOT SIZE1
EX-DIV DATE06/29/2022
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/28 13:00
RNA Biotechs: Current State And Outlook
TipRanks·03/28 12:47
Oppenheimer Reaffirms Their Buy Rating on Regulus (RGLS)
Reuters·03/28 07:22
U.S. RESEARCH ROUNDUP-Applied Materials, KLA, Oxford Industries
Dow Jones·03/27 18:16
Regulus Therapeutics Price Target Raised to $6.00/Share From $3.00 by Wells Fargo
Dow Jones·03/27 18:16
Regulus Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo
Benzinga·03/27 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·03/27 16:59
Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease
TipRanks·03/27 16:55
Wells upgrades Regulus to Overweight after farabursen data reported
TipRanks·03/27 16:50
Regulus upgraded to Overweight from Equal Weight at Wells Fargo
Seeking Alpha·03/27 16:10
Regulus jumps after data update from early-stage trial for kidney disease therapy
Benzinga·03/27 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Same Industry
Name/Symbol
Change%
Price